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Abstract
Background: The CRISPR/Cas9 system is a prokaryotic immune system that infers resistance to foreign genetic
material and is a sort of 'adaptive immunity'. It has been adapted to enable high throughput genome editing and
has revolutionised the generation of targeted mutations.
Results: We have developed a scalable analysis pipeline to identify CRISPR/Cas9 induced mutations in hundreds of
samples using next generation sequencing (NGS) of amplicons. We have used this system to investigate the best
way to screen mosaic Zebrafish founder individuals for germline transmission of induced mutations. Screening
sperm samples from potential founders provides much better information on germline transmission rates and
crucially the sequence of the particular insertions/deletions (indels) that will be transmitted. This enables us to
combine screening with archiving to create a library of cryopreserved samples carrying known mutations. It also
allows us to design efficient genotyping assays, making identifying F1 carriers straightforward.
Conclusions: The methods described will streamline the production of large numbers of knockout alleles in
selected genes for phenotypic analysis, complementing existing efforts using random mutagenesis.
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Background
The CRISPR/Cas9 system has emerged over recent years to
become the prevailing method for genome editing with
many different applications in a wide variety of organisms
[1–11]. Clustered Regularly Interspaced Short Palindromic
Repeats (CRISPR) are sequences found in many species of
bacteria and archaea, consisting of repeated sequences
interspersed with different non-repetitive sequences. These
spacer sequences are derived from previous viral infections
and the CRISPR/Cas system functions as an adaptive immune
response to viral infection [12–15]. CRISPR associated (Cas)
genes are arranged in operons next to CRISPR loci [16].
The endogenous type II CRISPR system is composed of a
CRISPR RNA (crRNA) derived from the spacer sequences
[17], a trans-activating RNA (tracrRNA; [18]) and the Cas9
endonuclease, which cuts at sequences complementary to
the crRNA [19]. The form most commonly used in genome
editing applications employs a single chimeric version of
crRNA and tracrRNA known as a synthetic guide RNA
(sgRNA). This can be used to efficiently induce small
insertions/deletions (indels), through inaccurate repair of
double-strand breaks, preferably generating frameshift
mutations to produce loss-of-function alleles for genes of
interest. Cas9 protein recognises a small motif known as the
proto-spacer adjacent motif (PAM), which is present in the
foreign sequence, but not in the CRISPR locus, allowing it to
distinguish self versus non-self [20–23]. For Streptococcus
pyogenes Cas9, the PAM sequence is NGG, leading to a con-
sensus CRISPR target site of N21GG. For sgRNAs produced
in vitro using a T7 promoter the first two transcribed bases
are G, making sgRNAs with a GGN19GG consensus [24, 25].
The CRISPR/Cas system has made it feasible to
generate targeted mutations on a large scale. Previous
approaches relied on either chemical or insertional
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mutagenesis [26–28], and while these were very success-
ful they suffer from a problem of diminishing returns,
because of their random nature. Also, genes that are
haploinsufficient will not be recovered by these strategies,
as F1s with such alleles will not survive to be screened.
The ability to disrupt gene function in a targeted high-
throughput manner provides a complementary approach
with the potential to realise the goal of producing a
knockout allele in every gene in the zebrafish genome.
Beyond that it will also make other genomic modifications
straightforward, enabling the study of non-coding portions
of the genome such as non-coding RNAs and enhancers.
The most time-consuming aspects of generating
mutants by CRISPR/Cas are screening and genotyping.
For example, sgRNAs need to be screened for cutting
efficiency as there is currently no reliable way of predict-
ing the activity of any given sgRNA. Mosaic sgRNA-
injected individuals then need to be screened for those
that transmit the appropriate alleles (e.g. frameshift
indels or missense mutations). Finally, individuals need
to be genotyped to identify those that are carrying such
alleles. Capillary sequencing is expensisve and not high
throughput and methods such as T7 endonuclease I
assay and High-Resolution Melt Analysis do not identify
which alleles are useful. Since G0-injected individuals
are mosaic for induced indels, there is also the problem
of what tissue to screen to best evaluate germline trans-
mission rates.
We have developed a scalable design and analysis
pipeline for the production of CRISPR/Cas9 mutants.
To streamline screening, we use high-throughput next
generation amplicon sequencing of sperm samples from
G0-injected males. This allows us to cryopreserve sperm
samples at the same time, producing an archive of
alleles. It also provides information on the specific
variants in the germline of each individual enabling us
to design genotyping assays to the particular variants in
each sample. This greatly simplifies the identification of
F1 carriers and allows us to segregate multiple different
alleles transmitted by the same founder.
Results and discussion
CRISPR/Cas9 sgRNA design
There are currently many web sites and programs for
designing sgRNAs and determining possible off-target
sites (see [29, 30] for summary) all with differing
strengths and weaknesses depending on the particular
application. For example, only a few allow design of
sgRNAs in batch. To facilitate the design of sgRNAs for
large numbers of target genes, we have created a set of
Perl modules and scripts (https://github.com/richysix/
Crispr). The modules define objects that represent com-
ponents involved in the design process such as a target
region of DNA, a CRISPR/Cas9 target site and PCR
primers. The scripts automate particular parts of the
process such as scoring CRISPR target sites and design-
ing PCR primers for amplicon sequencing. Since there is
currently no reliable way of predicting the cutting effi-
ciency of a given sgRNA, targets are selected to
minimize possible off-target effects.
The design process is illustrated in Fig. 1. The design
scripts take either Ensembl identifiers (gene, transcript
or exon) or genomic regions as input. Allowing arbitrary
regions as input enables design of sgRNAs to modify
non-coding regions such as promoters and enhancers. In
the search phase, the sequence is scanned for all possible
sites matching a given target sequence (e.g. GGN19GG).
These sites are scored for off-target potential. Currently,
off-target scoring is done by aligning target sequences
back to the reference genome using bwa, allowing an op-
tional number of mismatches. However, faster algo-
rithms for off-target finding exist [29, 31] and these will
be incorporated into the design module. All the possible
target sites are output with a score that reflects both off-
target potential and, if using Ensembl identifiers, the
position of the target site in the supplied gene/transcript.
Optionally, sites can be filtered based on known SNP
data to avoid possible mismatches to the target site in
the line being used.
Once CRISPR target sites have been selected, PCR
primers for screening sgRNA efficiency can be designed
using another script that runs Primer3 [32, 33] multiple
times to produce nested primer pairs. The Crispr pack-
age also contains a SQL (MySQL/SQLite) database
schema that holds information about target regions,
CRISPR sites, construction oligos, PCR primers etc.
There are also scripts to automatically load the informa-
tion into a database using the output files from the de-
sign scripts.
For this study, sgRNAs were designed as pairs to allow
larger than normal deletions to be made. In addition,
these pairs could be used with Cas9 nickase [7] rather
than native Cas9 if off-target effects proved to be a sig-
nificant issue. The criteria for picking pairs were as fol-
lows: pairs of sites were considered valid if the predicted
cut sites were between 30 and 100 bp apart and the
CRISPR sites were in a tail—tail orientation (i.e. the first
site targets the reverse strand and the second targets the
forward strand). Evidence from human cells showed that
such an orientation was much more efficient than
head—head when using Cas9 nickase [7]. The usual tar-
get sequence when designing sgRNAs for in vitro tran-
scription is GGN19GG to incorporate the end of the T7
promoter sequence [5, 25]. However, this makes finding
correctly spaced and oriented sites for designing pairs of
sgRNAs much less likely. To allow us to design pairs, we
relaxed the sequence constraint to N21GG and placed
two extra G nucleotides on the 5′ end, thus making the
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sgRNA 2 bases longer. Each pair of sgRNAs was injected
together using native Cas9 and screened for efficiency
using a single amplicon spanning both CRISPR sites. All
the target sequences for the sgRNAs used in this study
are in Additional file 1.
Generating mutants using CRISPR/Cas9
An illustration of our screening workflow for generating
mutants using the CRISPR/Cas9 system is shown in
Fig. 2. First, sgRNAs are designed by selecting target
sites with low off-target potential in the region of
interest. Generally, we find that selecting two target sites
per gene is enough to find at least one sgRNA that is
sufficiently active. RNA for microinjection is produced
in vitro using the method of Gagnon et al. [5], which
can be done in 96 well plates without any cloning steps.
To screen the activity of sgRNAs in a high-throughput
manner, we use PCR primers designed for use with the
MiSeq sequencing platform to amplify the region sur-
rounding the CRISPR target site. This allows us to
screen amplicons in hundreds to thousands of embryos
in a single sequencing run. Typically, we first assess
sgRNAs by injecting small numbers of embryos and
screening for cutting efficiency by amplicon sequencing
(Fig. 2b). Selected sgRNAs that efficiently induce indels
are re-injected and the embryos raised to adulthood.
Males are selected from these families and sperm is col-
lected for both cryopreservation and screening for germ-
line mutations, again by sequencing. The samples that
carry high frequency frameshift alleles are selected for in
vitro fertilisation (IVF) to produce F1 families. Screening
the germline of G0 founder fish allows us to design
KASP genotyping assays (LGC Genomics) for the spe-
cific variants that will be transmitted to the next gener-
ation enabling us to quickly identify F1 carriers for
incrossing and subsequent phenotyping.
Screening the germline by amplicon sequencing
The second part of the process of producing mutant lines
is identifying CRISPR-induced indels, for both initial effi-
ciency testing and recovery of transmitting alleles. Like
many groups [34–40], we have used high-throughput
sequencing of amplicons for identifying variants. The
Illumina MiSeq platform allows fast turnaround times and
provides enough reads to screen hundreds of samples over
many amplicons. Nested primers are designed to amplify a
Fig. 1 CRISPR sgRNA design process. An Ensembl gene model is shown at the top; two exons are expanded in the rest of the diagram. The target
sequence is searched for CRISPR sites, these are scored and the best scoring are selected. For screening, PCR primers are designed for making amplicons
into sequencing-ready libraries. The package also includes a database schema for storing information on CRISPR designs and screening information
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250–300 base pair (bp) region surrounding the CRISPR
target site. The internal primers have partial Illumina
adaptor sequence to allow for the creation of sequencing-
ready libraries by PCR. Amplicons from a single sample
(embryo/sperm sample) are barcoded using primers
containing Illumina adaptor sequence and an 11 bp
barcode (Fig. 1).
The analysis procedure is shown in Fig. 3a. First,
adaptor and primer sequence is trimmed from the reads
using cutadapt [41]. Large deletions within the amplicon
will result in the sequence reading into the adaptor se-
quence on the other side of the amplicon. Primer se-
quences are also trimmed to reduce the possibility of
false positives caused by primer-dimer contamination.
The trimmed reads are then mapped to the genome with
the BBMap aligner (sourceforge.net/projects/bbmap/).
BBMap is better able to map reads containing large
indels which is essential for this application.
These alignments are then analysed by a custom Perl
script that selects candidate alleles from the BBMap-
produced BAM files and downsamples the reads into
separate allele-specific BAM files [42]. These are analysed
using the program Dindel [43] to call the specific inser-
tions/deletions. The script then outputs each allele
found and its frequency within the sample. Two cus-
tom R scripts are used to produce graphical represen-
tations of the data. Examples of these are shown in
Fig. 3b. More detail on how to run the design and
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Fig. 2 CRISPR workflow. a Overall workflow. Diagram showing the steps of the process. b Strategy for sgRNA screening. Initially, sgRNAs are screened
for efficiency and those with high cutting efficiency are re-injected. The G0 embryos are raised and males are screened for germline CRISPR-induced
indels. For high-transmitting samples, embryos are generated by IVF, raised and the resulting F1 carriers are identified by KASP
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Screening somatic tissues versus the germline
To investigate the best way to screen potential founder
G0 individuals we compared the CRISPR-induced alleles
present in the germline and the soma. We isolated both
sperm and fin tissue from individual males from
CRISPR-injected families and analysed them by ampli-
con sequencing. We tested nine different sgRNAs for
five different genes.
The questions we were interested in were:
1. Is the percentage of reads showing an indel in the
fin clip predictive of the percentage of reads showing
an indel in the germline?
2. Do the variants found in the fin clip reflect the ones
in the germline?
As shown in Fig. 4. the complement of alleles found
differs greatly between the two samples. Overall, there is
a correlation between the percentage of reads with an
indel in each tissue (Fig. 4a), although there are many
clear examples where this is not the case (i.e. a fin clip
with a high percentage where the sperm sample has a
low percentage and vice versa). The correlation between
the percentage of reads showing an indel in the fin clip
and the percentage of reads showing an indel in the
sperm sample ranges from −0.158 to 0.928 across the
nine sgRNAs (Additional file 3: Figure S1a), however this
may be misleading due to differences in efficiency
between the sgRNAs. Importantly, the frequencies of
specific alleles do not correlate well between the tissues
(Fig. 4b-c). Indeed, 27 of the 92 samples showed variants
in the fin-clip sample and no variants in the germline. In
addition, of the 1150 variants identified across all sam-
ples, only 77 were shared between the fin clip and the
sperm sample of the same individual. This means that it
is not possible to predict which, if any, of the variants
seen in the fin-clip sample will be transmitted to the
next generation.
Given the high efficiency of most CRISPR sgRNAs, it is
feasible to recover F1 fish carrying induced indels by
screening fin-clip DNA. However, these data show that
screening fin clips of G0 individuals is not predictive of
the germline transmission rates or the transmitted alleles.
Direct genotyping of F1s by KASP genotyping
Another important benefit of directly screening the
germline of potential founders is that it allows us to
know exactly which alleles will be transmitted to the
next generation, removing the need to sequence F1 indi-
viduals. We can design KASP genotyping assays (LGC
Genomics) for the transmitted alleles in advance of the
F1 individuals being old enough to cross. This allows us
to rapidly screen F1 individuals for the transmitted al-
leles that they carry by simple fin clipping and genotyp-
ing PCR. Figure 4d shows the frequencies of variants
called from sperm sequencing data plotted against the
Fig. 3 Crispr analysis pipeline. a Analysis pipeline. Schematic of sequence analysis procedure. b Pipeline outputs. Examples of the visualisations
that the pipeline produces. Top—plate map showing the percentage of reads containing an indel for each sample along with the total number
of reads. Bottom—display of induced variants relative to the CRISPR target site
Brocal et al. BMC Genomics  (2016) 17:259 Page 5 of 10
frequencies of carriers identified in F1 individuals by
KASP for sgRNAs that have been taken through the
complete pipeline. Variant frequencies called from
amplicon sequencing correlate well with the number of
carriers identified in F1 offspring. This provides confirm-
ation that our indel calling is working well and allows us
to use the frequencies reported from amplicon sequen-
cing as a guide as to which sperm samples to select for
IVF to generate the most F1 carriers.
Another different workflow would be to screen F1 em-
bryos from G0 incrosses by sequencing to identify high
transmitting pairs, which can then be recrossed. Indeed,
similar results to ours have been reported using this
scheme by Varshney et al [34]. They showed that only
3.8 % (99/2618) of somatic mutations identified in fin clips
were transmitted to the F1 generation. Screening F1 em-
bryos may be a preferable workflow for labs that do not
routinely cryopreserve sperm although sperm samples can
be screened without having to cryopreserve them.
However, screening F1 embryos requires keeping living
fish housed as pairs until the analysis is completed and
then for a second cross to be carried out following ana-
lysis. Screening G0 sperm is a streamlined workflow that
involves less fish work to identify loss-of-function alleles.
GGN21GG sgRNAs have reduced efficiency compared to
GGN19GG ones
Using this system we have designed and screened the effi-
ciency of 90 sgRNAs designed to 45 genes (two per gene).
These sgRNAs were designed as pairs as detailed above.
After screening all 90 sgRNAs for efficiency we could see
that a large proportion of them had very low activity. To
investigate whether the GGN21GG design was the cause
of this, we redesigned the lowest efficiency sgRNAs as
single GGN19GG sites. As shown in Fig. 5, these sgRNAs
are significantly more active (Wilcoxon rank sum test with
continuity correction, P < 2.2 x 10−16). There are multiple
possible explanations for this. First, the increased length of
the sgRNA may affect efficiency. Second, mismatches
between the 5′ Gs and the genomic sequence may reduce
cutting efficiency. Thirdly, it is possible that the dif-
ference is due to the different target sites selected for
each of the designs.
We think that this last possibility is unlikely given the
effect size and number of sgRNAs tested. It has previ-
ously been reported that the Cas9 system can tolerate
mismatches in the 5′ end of the sgRNA [1, 3, 44]. Inter-
estingly, it has been reported in human systems that
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Comparison of MiSeq and KASP genotyping results
Fig. 4 Comparison of induced indels between germline and somatic tissues. a Plot of total percentage of reads with an indel in sperm versus fin
clip. b Plot of frequencies for individual variants in sperm versus fin clip. Variants that are present in both the sperm and fin-clip samples from a
single individual are in red. Plot has been cropped to make points near the origin easier to distinguish. Figure S2 is the original. c Plot showing
the average overlap of indels in each tissue for each sgRNA. d Plot showing the correlation between the frequency of reads from MiSeq data and
the number of carriers identified in F1 outcrosses
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reduces off-target cutting [45]. Cho et al. compared on-
and off-target cutting efficiency for three different target
sites using either GGN21GG or GN20GG for the design.
All three targets showed decrease off-target cutting effi-
ciency. However, for two of the target sites, the GGN20GG
designs were also significantly less active at the on-target
site than the corresponding GN20GG design.
Therefore, we favour the idea that it is the increased
length causing the decreased efficiency. Another group [34]
has also recently reported reduced cutting efficiency with
the same GGN21GG design compared to GGN19GG.
Conclusions
We have developed a system for designing and analysing
CRISPR Cas9 sgRNAs in batch. The Crispr package is
freely available and can be downloaded from GitHub
(https://github.com/richysix/Crispr). We have developed
an efficient germline screening platform using NGS. We
have used this system to compare the variants found in
the germline and somatic tissues of founder individuals
and have shown that, in zebrafish, somatic tissues are
not predictive of the alleles (or their frequencies) that
are transmitted to the next generation. We have also ob-
served a decrease in efficiency of sgRNAs designed using
a different consensus sequence. It would also be possible
to extend our method to screen multiple amplicons in
the same samples, allowing screening of injections of
multiplexed sgRNAs, as well as using it to screen sam-
ples for precise genomic changes rather than indels.
Methods
Crispr package
Instructions for how to use the Crispr package can be
found at github.com/richysix/Crispr/. Details on the
bioinformatics pipeline are supplied as a tutorial in
Additional file 2.
Design of sgRNAs
The sgRNAs used in this study were designed using both
the crispr_pairs_for_deletions.pl and find_and_score_
crispr_sites.pl scripts from the Crispr package. The first 90
sgRNAs were designed as pairs with a minimum separ-
ation of 30 bp and a maximum of 100 with a target
consensus of N21GG. Two G bases were then added to the
5′ end of the oligos to produce the sgRNAs using T7 RNA
polymerase. Low efficiency sgRNA pairs were redesigned as
single guides using a target consensus of GGN19GG.
Production of sgRNAs
To generate templates for sgRNA transcription we used
the method of Gagnon et al. [5]. Target-specific oligonu-
cleotides containing the T7 promoter sequence, the tar-
get site without the PAM, and a complementary region
were annealed to a constant oligonucleotide encoding
the reverse complement of the tracrRNA. The ssDNA
overhangs were filled in with T4 DNA polymerase
(NEB), and the resulting sgRNA template were purified
using Qiaquick columns (Qiagen). We used MegaShort-
Script T7 kit (Life Technologies) to synthesise sgRNAs.
All sgRNAs were then DNase treated and precipitated
with ammonium acetate/ethanol. Cas9 mRNA was tran-
scribed from linearised pCS2- nls-zCas9-nls plasmid
using mMessage Machine SP6 kit (Life Technologies),
DNase treated, and purified by phenol–chloroform ex-
traction and EtOH precipitation. RNA concentration
was quantified using Qubit spectrophotometer and di-
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Comparison of efficiency between different sgRNA designs
Fig. 5 Efficiency of longer sgRNAs. a Longer sgRNAs (GGN21GG) tend to be less efficient than those designed to the usual consensus (GGN19GG).
Plot shows the distribution of the mean indel frequency for sgRNAs with different design strategies. b Plot showing the distribution of induced indel
frequencies for individual sgRNAs with different design strategies
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Zebrafish husbandry
Zebrafish were maintained in accordance with UK Home
Office regulations, UK Animals (Scientific Procedures)
Act 1986, under project licence 70/7606, which was
reviewed by the Wellcome Trust Sanger Institute Ethical
Review Committee. Embryos were obtained either
through natural matings or in vitro fertilisation and main-
tained in an incubator at 28.5 °C up to 5 days post fertil-
isation (dpf).
MicroInjection
Approximately 1 nl total volume of 10 ng/ul (sgRNAs)
and 200 ng/ul (Cas9 mRNA) was injected into the cell of
one-cell stage embryos. We routinely inject 150–200
embryos per CRISPR sgRNA, raise 100 embryos and MiSeq
screen 24 embryos at 24–48 h post fertilization (hpf).
Cryopreservation of alleles
Sperm samples from G0 sgRNA-injected males were
cryopreserved as previously described [46]. We usually
archive sperm from 12 individuals if available. Sperm
samples are split into three; two are frozen and the third
is used for screening by amplicon sequencing.
Screening by amplicon sequencing
Illumina library prep
To detect indels in F0 embryos, 22 injected embryos and
2 non-injected embryos were individually lysed at 24–48
hpf by Hot Shot method [47]. To detect indels in fin
clips and sperm, samples were lysed using DNA extrac-
tion buffer (100 mM Tris pH 8.2, 5 mM EDTA, 200 mM
NaCl, 0.2 % SDS, 100 μg/ml proteinase K) overnight at
55 °C, followed by heat inactivation of proteinase K at
80 °C for 30 min and isopropanol precipitation.
The Crispr package was used to design screening
primers around each CRISPR target site. The amplicons
were fixed at 250–300 bp and the sgRNA site was always
offset so the sequencing efficiently covers it. The
software designs nested primers in the first PCR. The
second (internal) set of PCR primers have partial
Illumina adaptor sequence at the 5′ end, so that the
product from the second PCR can be re-amplified with
full-length Illumina adaptor primers (barcoded if re-
quired). We used a set of 384 barcoded Illumina adaptor
primers in the third PCR.
PCR amplifications were performed with KOD Hot
Start DNA Polymerase (Novagen) following the manual
and Touch down (−0.5 °C/cycle) PCR conditions: 95 °C
2 min; 18 cycles 95 °C 20 s, 65 °C→ 56 °C 20 s, 70 °C 20 s;
30 cycles 95 °C 20 s, 56 °C 20 s, 70 °C 20 s; 70 °C 1 min.
PCRs were checked by gel electrophoresis for the right
amplicon size and the third PCRs were pooled and run on
a 150 bp paired-end Miseq sequencing run.
Variant calling
Amplicon analysis was performed using the count_
indel_reads_from_bam.pl script from the Crispr package.
Before running the script, the reads are split into individual
sample FASTQ files based on the barcodes. The reads were
then trimmed to remove adaptor contamination and pri-
mer sequence using cutadapt [41]. Reads were filtered
post-trimming to remove any reads trimmed to smaller
than 50 bp. Trimmed and filtered reads were mapped to
the zebrafish genome (Zv9 assembly; [48]) using BBMap
(sourceforge.net/projects/bbmap/). The resulting BAM files
were used as the input files for count_indel_reads_from_
bam.pl. The script requires a YAML configuration file de-
tailing which BAM files to analyse for which amplicons/
sgRNAs. These were produced from an instance of the
Crispr package MySQL database, but could be produced
by hand. The data for the sperm vs fin-clip anlaysis are in
Additional files 4 and 5. The output files from the efficiency
screening were collated into a single file (Additional file 6:
fig_5_data.tsv) for subsequent analysis.
KASP genotyping
Genotyping of potential F1 carriers was performed using
the competitive allele-specific PCR (KASP) system (LGC
Genomics Ltd. Hoddesdon, UK; http://www.lgcgroup.
com/products/kasp-genotyping-chemistry) on fin-clip
biopsies as previously described [46].
Statistical analysis
Data analysis was carried out using R v3.1.3 [49]. Plots were
created using ggplot 1.01 [50]. The data and code to
produce the plots is provided in Additional files 4, 5, 6 and 7.
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